Startups channel feed – Endpoints News

Startups channel feed

SoftBank's newest, $165M biotech investment looks for infectious traces in the blood

6 years ago

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

6 years ago

Fresh off $100M round, GV-backed real-world data startup woos Duke researcher as CMO

6 years ago

Drug discovery in HD: Oxford spinoff's mass spectrometry approach scores fresh funding

6 years ago

Corey Goodman marshals $105M mega-round for his CD47 upstart, looking to break new ground in PhII

6 years ago

From mice to dogs, and someday man: George Church's gene therapy cocktail for aging-related diseases

6 years ago

Dutch biotech scores €25M in small molecule bet to tackle lysosomal storage disorders

6 years ago

The Sanofi-partnered startup finding clinical trials for the 90%

6 years ago

F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B

6 years ago

Striving for higher res imaging of cells, Harvard team debuts startup with backing from ARCH, Northpond

6 years ago

Flagship's first venture of 2020 is out, and it's all about sperm

6 years ago

Ex-Novartis CEO Joe Jimenez is taking another crack at opening a new chapter in his career — and that includes a new board seat and a $250M startup

6 years ago

Bruce Booth and Samantha Truex's latest venture aims just above Humira

6 years ago

Merck KGaA spinout gets first funding to bring dual-acting cancer molecules into the clinic

6 years ago

French-Belgian biotech banks €20M to break ground in blood-splattered field of therapeutic cancer vaccines

6 years ago

Boehringer, Novo-backed German biotech banks €11M in liver regeneration push

6 years ago

Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives

6 years ago

Gates vets at Adjuvant back Codagenix's software-driven approach to recoding RSV, flu, oncolytic viruses and more

6 years ago

RA Capital, Canaan help infuse $50M into Alta-incubated biotech battling acquired resistance to TKIs

6 years ago

DCVC Bio, 5AM back colonizing army of genetically engineered gut bacteria with $33M

6 years ago

Primed for attack: Vaccine tech maker gets $11M shot to battle infectious disease

6 years ago

Shreds of Tregs: French biotech wins Medicxi backing to kill the rogue immunosuppressive agent to fight cancer

6 years ago

Stanley and Rosanne Crooke stay focused on anti-sense, stealing back patients from disease with N-of-1 tech

6 years ago

Fish oil pill for NASH? Dutch biotech scores $40M injection to make a mark in the bustling field

6 years ago

First page Previous page 53 54 555657 58 59 Next page Last page